|
Market Closed -
Nasdaq
04:00:00 2026-10-07 pm EDT
|
5-day change | 1st Jan Change | ||
| 413.08 USD | +2.60% |
|
-2.00% | +26.20% |
| Oct. 07 | Nasdaq Composite, S&P 500 Fall From Record Following Fed Meeting Minutes | MT |
| Oct. 07 | Pharmaceutical Group Sues US Government Over Medicare Drug Pricing Rule | MT |
| Market Cap | 218B 194B 181B 165B 310B 21,061B 313B 2,176B 850B 10,707B 817B 799B 34,392B | P/E 2026 * |
25.4x | P/E 2027 * | 22.8x |
|---|---|---|---|---|---|
| Enterprise Value | 259B 231B 216B 196B 369B 25,076B 372B 2,591B 1,012B 12,748B 973B 952B 40,949B | EV / Sales 2026 * |
6.66x | EV / Sales 2027 * | 6.28x |
| Free-Float |
99.77% | Yield 2026 * |
2.51% | Yield 2027 * | 2.65% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AMGN | Delayed | |
CBOE
| AMGN | Real-time | |
|
Mexican S.E.
| AMGN * | End-of-day quote | |
|
Boerse Muenchen
| AMG | Real-time | |
|
Xetra
| AMG | Delayed | |
|
Tradegate
| AMG | Real-time | |
|
London S.E.
| 0R0T | Delayed | |
|
CBOE
| 0R0T | Real-time | |
|
CBOE
| Real-time | ||
|
Deutsche Boerse AG
| AMG | Delayed | |
|
Wiener Boerse
| AMGN | End-of-day quote | |
|
Börse Stuttgart
| AMG | Delayed | |
|
Berne S.E.
| 000907582 | End-of-day quote | |
|
Borsa Italiana
| 1AMGN | End-of-day quote | |
|
Santiago S.E.
| AMGN | End-of-day quote | |
|
Santiago S.E.
| AMGNCL | End-of-day quote |
Last Transcript: Amgen Inc.
| 1 day | +2.60% | ||
| 1 week | -2.49% | ||
| Current month | -2.00% | ||
| 1 month | -5.52% | ||
| 3 months | +12.73% | ||
| 6 months | +20.58% | ||
| Current year | +26.20% |
| 1 week | 396.01 |  | 422.8 |
| 1 month | 374.46 | | 426.59 |
| Current year | 318.21 | | 447.03 |
| 1 year | 288 | | 447.03 |
| 3 years | 249.7 | | 447.03 |
| 5 years | 198.64 | | 447.03 |
| 10 years | 133.64 | | 447.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 2012-04-30 |
| Director of Finance/CFO | 62 | 2010-05-12 | |
Paul Burton
CTO | Chief Tech/Sci/R&D Officer | 57 | 2023-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 63 | 2012-12-31 |
Tyler Jacks
BRD | Director/Board Member | 65 | 2011-12-31 |
Robert Eckert
BRD | Director/Board Member | 71 | 2011-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/1/26 | Other | Chief Financial Officer | 34,061 | 0.0063% | ||
| 8/13/26 | Exercice | Executive/Senior Manager | 3,756 | 0.0007% | ||
| 8/7/26 | Free | Director | 85 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.60% | -2.49% | +40.45% | +54.44% | 218B | |
| +2.70% | +0.35% | +40.67% | +110.31% | 1,032B | |
| +1.44% | -3.41% | +37.36% | +63.95% | 614B | |
| +1.75% | +3.07% | +17.89% | +83.05% | 471B | |
| +0.60% | -4.35% | +60.80% | +37.46% | 350B | |
| +2.92% | +3.06% | +24.83% | +45.10% | 337B | |
| +2.42% | -0.74% | +13.44% | +35.80% | 268B | |
| +1.86% | -0.81% | -4.69% | +12.20% | 246B | |
| +1.82% | -2.93% | +29.29% | +96.48% | 179B | |
| +3.40% | +0.28% | -32.42% | -60.33% | 164B | |
| Average | +1.38% | -3.29% | +22.76% | +47.85% | 387.85B | |
| Weighted average by Cap. | +0.80% | -3.15% | +29.43% | +65.06% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.94B 34.76B 32.43B 29.46B 55.51B 3,768B 55.94B 389B 152B 1,915B 146B 143B 6,153B | 40.34B 36.02B 33.59B 30.52B 57.5B 3,903B 57.95B 403B 158B 1,984B 151B 148B 6,374B |
| Net income | 8.58B 7.66B 7.15B 6.49B 12.23B 830B 12.33B 85.77B 33.52B 422B 32.21B 31.51B 1,356B | 9.39B 8.39B 7.82B 7.11B 13.39B 909B 13.49B 93.89B 36.69B 462B 35.26B 34.5B 1,484B |
| Net Debt | 41.5B 37.05B 34.56B 31.4B 59.15B 4,015B 59.61B 415B 162B 2,041B 156B 152B 6,557B | 35.77B 31.94B 29.79B 27.07B 51B 3,462B 51.39B 358B 140B 1,760B 134B 131B 5,653B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-07 | $413.08 | +2.60% | 2,236,602 |
| 26-10-06 | $402.60 | -0.09% | 2,036,870 |
| 26-10-05 | $402.98 | -0.01% | 3,104,125 |
| 26-10-02 | $403.04 | -1.04% | 3,510,312 |
| 26-10-01 | $407.27 | -3.38% | 2,501,030 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMGN Stock
Select your edition
All financial news and data tailored to specific country editions
